SCHEMBL734898

SCHEMBL734898

COC(=O)[C@H](CCO)N1CCN(c2ccccc2)CCC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 5/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 1/20 0.40
MAPK1 P28482 3/20 0.40
TP53 P04637 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 5/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
NPY2R P49146 1/20 0.39
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL734899 1.00 GFER (0.45) GFERPOLBMAPTALDH1A1HTT
SCHEMBL733759 0.86 LDHA (0.46) MAPTHTTTP53KMT2AMEN1
SCHEMBL733758 0.86 LDHA (0.46) MAPTHTTTP53KMT2AMEN1
SCHEMBL734351 0.85 GFER (0.44) GFERPOLBMAPTALDH1A1HTT
SCHEMBL734352 0.85 GFER (0.44) GFERPOLBMAPTALDH1A1HTT
SCHEMBL734487 0.85 NOTUM (0.44) POLBSMN1; SMN2LMNA
SCHEMBL736396 0.85 POLB (0.53) POLBMAPTALDH1A1HTTMAPK1
SCHEMBL735608 0.85 POLB (0.53) POLBMAPTALDH1A1HTTMAPK1
SCHEMBL734488 0.85 NOTUM (0.44) POLBSMN1; SMN2LMNA
SCHEMBL735607 0.85 POLB (0.53) POLBMAPTALDH1A1HTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138175-B2 Heterocyclyl compounds HOFFMANN-LA ROCHE INC. (US) 2012-03-20 US disclosed
EP-2321285-A1 DIAZEPAN AND PIPERAZINE DERIVATIVES MODULATORS OF CHEMOKINE RECEPTORS F. Hoffmann-La Roche AG (CH) 2011-05-18 EP disclosed
WO-2010012619-A1 DIAZEPAN AND PIPERAZINE DERIVATIVES MODULATORS OF CHEMOKINE RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2010-02-04 WO disclosed
US-20100022518-A1 NOVEL HETEROCYCLYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022518-A1 NOVEL HETEROCYCLYL COMPOUNDS CCR2, CCR3, CCR5 GFER 4102/4885POLB 4167/4885MAPT 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.